a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication

Launched by THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA · Feb 19, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on predicting complications that may occur after a procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP), which is used to diagnose and treat issues in the bile and pancreatic ducts. The researchers aim to develop models that can help doctors identify patients who are more likely to experience problems after the procedure, both before and after it happens.

To participate in this trial, you need to be someone who is scheduled for a routine ERCP. Unfortunately, if you are pregnant, breastfeeding, currently dealing with acute pancreatitis, or if you do not want to be part of the study, you won’t be eligible. If you decide to join, you can expect to undergo the usual ERCP procedure and provide information that will help improve the safety and effectiveness of this treatment for future patients. The trial is currently looking for participants, and everyone, regardless of gender, within the age range of 65 to 87, is welcome to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Routine ERCP patients
• Exclusion Criteria:
• • Unwillingness or inability to consent for the study
• • Pregnant women or breastfeeding
• • current acute pancreatitis